MeMed announced today that it has raised $93 million to boost the manufacturing and commercialization of its host immune response diagnostics. The company, based out of Haifa, Israel and Boston, has raised a total of $200 million, including support from the U.S. Department of Defense and EU Commission. The latest money-raise includes new and existing […]
memed
MeMed wins $9.2m DoD deal for diagnostic device
MeMed said today that it won a $9.2 million contract from the Defense Threat Reduction Agency, a branch of the U.S. Dept. of Defense, for its diagnostic platform that distinguishes bacterial infections from viral infections. The Israel-based company has developed a test to recognize the distinct human immune signatures of both bacterial and viral infections […]